Skip to main content

HCA Healthcare, Inc.

corporate_fare Company Profile

HCA Healthcare, Inc.

HCA·NYSE·Industrial Applications And Services·CIK 0000860730

HCA Healthcare, Inc. is a leading healthcare services company in the United States. As of December 31, 2025, the company operated 190 hospitals, which included 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. Additionally, HCA Healthcare operated 121 freestanding ambulatory surgery centers and 31 freestanding endoscopy centers. Its facilities are located across 19 states and England. The company's primary goal is to deliver a wide range of quality healthcare services as cost-effectively as possible. Its general acute care hospitals offer comprehensive services for medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics, and obstetrics, alongside diagnostic and emergency services. Outpatient and supporting healthcare services are provided through its general acute care hospitals, ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, physician practices, diagnostic centers, home health agencies, hospices, and rehabilitation facilities, among others. The behavioral hospitals provide a full spectrum of mental health care services in inpatient, partial hospitalization, and outpatient settings. HCA Healthcare, Inc. was incorporated in Delaware in October 2010, building on operations that began in 1968 through its predecessors. Its common stock is traded on the New York Stock Exchange under the symbol "HCA."

HCA Healthcare, Inc. (NYSE:HCA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 30 items for HCA at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • HCA Healthcare Announces Proposed Senior Note Offering to Refinance $2.5 Billion in Debt
  • HCA Plans Senior Notes Offering, Potentially $4 Billion, to Refinance Debt
  • HCA Healthcare Shares Drop 7.6% Premarket as Q1 Profit Beat Overshadowed by Weak Flu Season Volumes
  • HCA Healthcare Beats Q1 EPS Estimates, Reaffirms Guidance, and Repurchases $1.57B in Shares
  • HCA Healthcare Faces Shareholder Scrutiny Over Acquisitions and Governance at Upcoming Annual Meeting

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$75.6B
Net Income
$6.78B
Diluted EPS
$28.33
Op. Cash Flow
$12.64B
Free Cash Flow
$7.69B
Cash & Equivalents
$1.04B
Total Debt
$46.49B
Debt / Equity
-7.71×
Net Margin
9.0%
Shares Outstanding
224.61M sh
Source: 10-K · filed 2026-02-10 · accession 0001193125-26-044769
$476 +0.09% today
52-week range · as of 2026-10-29 $353.99 – $556.52
Market cap
$99.34B
Volume
1.6M (1.1× avg)
3-mo avg 1.4M
Live data · 2026-11-22 03:35 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HCA - Filings & News (Page 2)

HCA
Apr 27, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $448.80
Real-time Price: $476.00 info
Change: +$27.20 (+6%) info
Market Cap: $99.343B info
HCA
Apr 27, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $434.70
Real-time Price: $476.00 info
Change: +$41.30 (+10%) info
Market Cap: $99.343B info
HCA
Apr 24, 2026, 7:13 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $449.99
Real-time Price: $476.00 info
Change: +$26.01 (+6%) info
Market Cap: $99.343B info
HCA
Apr 24, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $437.00
Real-time Price: $476.00 info
Change: +$39.00 (+9%) info
Market Cap: $99.343B info
HCA
Mar 13, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $532.97
Real-time Price: $476.00 info
Change: -$56.97 (-11%) info
Market Cap: $99.343B info
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $502.05
Real-time Price: $476.00 info
Change: -$26.05 (-5%) info
Market Cap: $99.343B info
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $502.05
Real-time Price: $476.00 info
Change: -$26.05 (-5%) info
Market Cap: $99.343B info
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $502.05
Real-time Price: $476.00 info
Change: -$26.05 (-5%) info
Market Cap: $99.343B info
HCA
Feb 10, 2026, 4:27 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $502.05
Real-time Price: $476.00 info
Change: -$26.05 (-5%) info
Market Cap: $99.343B info
HCA
Jan 27, 2026, 7:12 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $473.00
Real-time Price: $476.00 info
Change: +$3.00 (+0.63%) info
Market Cap: $99.343B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets